A Study of Bevacizumab (Avastin®) in Combination With Temozolomide and Radiotherapy in Participants With Newly Diagnosed Glioblastoma
Clinical trial NCT00943826 · COMPLETED
Trial details
- NCT number
- NCT00943826
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-29
- Primary completion
- 2013-02-28
- Enrollment
- 921
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.